Quantcast
Home » Topics » irregular heart rhythms

New anti-clotting drug saves lives in study

PARIS (Reuters) – An experimental anti-clotting drug from Bristol-Myers Squibb and Pfizer saved more lives than standard treatment warfarin in a major study, giving it an edge over rivals in an emerging multibillion-dollar market. Although Eliquis will be third to market among a wave of new oral anticoagulants, the data…

Google+